Stockreport

Translate Bio to Participate in Upcoming Investor Conferences

Telesis Bio, Inc.  (TBIO) 
PDF LEXINGTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new cla [Read more]